Registered entities
Triplet Therapeutics, Inc.
Reg. No. 83-1799943Belgium
Innovation
10 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 513 times.
| Year | Filings |
|---|---|
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 8 |
Investor mix
6 investors on record; lead investors include Pfizer.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 33% |
| Private equity | 1 | 17% |
| Other / undisclosed | 3 | 50% |